Moreover, the expression level of RAE1 was found to have the ability to accurately distinguish tumor tissues from normal tissues, and it could predict the 1-, 3-, and 5-year survival rates, which suggested that it could be used as a potential biomarker for the diagnosis and prognosis of HCC patients. Here, RAE1 is linked to hepatocellular carcinoma.